Authors: Orlando, C Raggi, CC Bagnoni, L Sestini, R Briganti, V La Cava, G Bernini, G Tonini, G Pazzagli, M Serio, M Maggi, M

Citation: C. Orlando et al., Somatostatin receptor type 2 gene expression in neuroblastoma, measured bycompetitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium-111-pentetreotide, MED PED ONC, 36(1), 2001, pp. 224-226

Authors: Sestini, R Vivarelli, R Balestri, P Ammannati, F Montali, E Papi, L

Citation: R. Sestini et al., Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene, HUM GENET, 107(4), 2000, pp. 366-371

Authors: Vona, G Caldini, A Sestini, R Rapi, S Bianchi, S Fanelli, A Pazzagli, M Orlando, C

Citation: G. Vona et al., The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples, CLIN CH L M, 37(6), 1999, pp. 649-654

Authors: Ragazzini, P Gamberi, G Benassi, MS Orlando, C Sestini, R Ferrari, C Molendini, L Sollazzo, MR Merli, M Magagnoli, G Bertoni, F Bohling, T Pazzagli, M Picci, P

Citation: P. Ragazzini et al., Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma, CANCER DET, 23(2), 1999, pp. 129-136